NasdaqGS:AMGNBiotechs
Amgen CFO Change Puts Focus On Debt, Growth And Capital Discipline
Amgen announced that long-serving CFO Peter Griffith will retire from his role.
Thomas Dittrich has been appointed as incoming CFO, with the transition marking a key governance change.
For investors watching Amgen, ticker NasdaqGS:AMGN, this leadership shift arrives with the stock trading around $331.57 and showing multi year gains, including 25.9% over the past year and 64.3% over three years. These figures frame the CFO transition as a governance development at a company that has...